|
1
|
Shehjar F, Maktabi B, Rahman ZA, Bahader
GA, James AW, Naqvi A, Mahajan R and Shah ZA: Stroke: Molecular
mechanisms and therapies: Update on recent developments. Neurochem
Int. 162:1054582023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu S, Wu B, Liu M, Chen Z, Wang W,
Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al: Stroke in
China: Advances and challenges in epidemiology, prevention, and
management. Lancet Neurol. 18:394–405. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barthels D and Das H: Current advances in
ischemic stroke research and therapies. Biochim Biophys Acta Mol
Basis Dis. 1866:1652602020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martin S: Stroke: Does intensive blood
sugar control improve prognosis? Dtsch med Wochenschr.
137:26282012.(In German). PubMed/NCBI
|
|
5
|
Wu X, You J, Chen X, Zhou M, Ma H, Zhang T
and Huang C: An overview of hyperbaric oxygen preconditioning
against ischemic stroke. Metab Brain Dis. 38:855–872. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shin TH, Lee DY, Basith S, Manavalan B,
Paik MJ, Rybinnik I, Mouradian MM, Ahn JH and Lee G: Metabolome
changes in cerebral ischemia. Cells. 9:16302020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tuo QZ, Zhang ST and Lei P: Mechanisms of
neuronal cell death in ischemic stroke and their therapeutic
implications. Med Res Rev. 42:259–305. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Virani SS, Alonso A, Benjamin EJ,
Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR,
Cheng S, Delling FN, et al: Heart disease and stroke
statistics-2020 update: A report from the american heart
association. Circulation. 141:e139–e596. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Przykaza Ł: Understanding the connection
between common stroke comorbidities, their associated inflammation,
and the course of the cerebral ischemia/reperfusion cascade. Front
Immunol. 12:7825692021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rothwell PM, Algra A and Amarenco P:
Medical treatment in acute and long-term secondary prevention after
transient ischaemic attack and ischaemic stroke. Lancet.
377:1681–1692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo J, Tuo Q and Lei P: Iron, ferroptosis,
and ischemic stroke. J Neurochem. 165:487–520. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Cao F, Yin H, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu L, Liu Y, Chen X, Zhong H and Wang Y:
Ferroptosis in life: To be or not to be. Biomed Pharmacother.
159:1142412023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Li Q, Guo H and He Q: Ferroptosis
and iron metabolism after intracerebral hemorrhage. Cells.
12:902022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen GH, Song CC, Pantopoulos K, Wei XL,
Zheng H and Luo Z: Mitochondrial oxidative stress mediated
Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radic Biol
Med. 180:95–107. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Chen P, Zhai B, Zhang M, Xiang Y,
Fang J, Xu S, Gao Y, Chen X, Sui X and Li G: The emerging role of
ferroptosis in inflammation. Biomed Pharmacother. 127:1101082020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Wan Y, Jiang Y, Zhang L and Cheng
W: GPX4: The hub of lipid oxidation, ferroptosis, disease and
treatment. Biochim Biophys Acta Rev Cancer. 1878:1888902023.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Shen T, Lian J, Deng K, Qu C, Li
E, Li G, Ren Y, Wang Z, Jiang Z, et al: Resveratrol reduces
ROS-induced ferroptosis by activating SIRT3 and compensating the
GSH/GPX4 pathway. Mol Med. 29:1372023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Snezhkina AV, Kudryavtseva AV, Kardymon
OL, Savvateeva MV, Melnikova NV, Krasnov GS and Dmitriev AA: ROS
generation and antioxidant defense systems in normal and malignant
cells. Oxid Med Cell Longev. 2019:61758042019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M,
Wang L, Zhang Y and Liu X: Rehmannioside A improves cognitive
impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2
and SLC7A11/GPX4 signaling pathway after ischemia. J
Ethnopharmacol. 289:1150212022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Henning Y, Blind US, Larafa S, Matschke J
and Fandrey J: Hypoxia aggravates ferroptosis in RPE cells by
promoting the Fenton reaction. Cell Death Dis. 13:6622022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kosman DJ: Redox cycling in iron uptake,
efflux, and trafficking. J Biol Chem. 285:26729–26735. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee J and Hyun DH: The interplay between
intracellular iron homeostasis and neuroinflammation in
neurodegenerative diseases. Antioxidants (Basel). 12:9182023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Recalcati S, Gammella E and Cairo G:
Dysregulation of iron metabolism in cancer stem cells. Free Radic
Biol Med. 133:216–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan F, Xu W, Ding J and Wang C:
Elucidating the progress and impact of ferroptosis in hemorrhagic
stroke. Front Cell Neurosci. 16:10675702023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weiland A, Wang Y, Wu W, Lan X, Han X, Li
Q and Wang J: Ferroptosis and its role in diverse brain diseases.
Mol Neurobiol. 56:4880–4893. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Q, Han X, Lan X, Gao Y, Wan J, Durham
F, Cheng T, Yang J, Wang Z, Jiang C, et al: Inhibition of neuronal
ferroptosis protects hemorrhagic brain. JCI Insight. 2:e907772017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Speer RE, Karuppagounder SS, Basso M,
Sleiman SF, Kumar A, Brand D, Smirnova N, Gazaryan I, Khim SJ and
Ratan RR: Hypoxia-inducible factor prolyl hydroxylases as targets
for neuroprotection by ‘antioxidant’ metal chelators: From
ferroptosis to stroke. Free Radic Biol Med. 62:26–36. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Y, Li K, Zhao Y, Zhou L, Liu Y and Zhao
J: Role of ferroptosis in stroke. Cell Mol Neurobiol. 43:205–222.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Guo ZN, Yan XL, Huang S, Ren JX,
Luo Y and Yang Y: Crosstalk between autophagy and ferroptosis and
its putative role in ischemic stroke. Front Cell Neurosci.
14:5774032020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bao WD, Pang P, Zhou XT, Hu F, Xiong W,
Chen K, Wang J, Wang F, Xie D, Hu YZ, et al: Loss of ferroportin
induces memory impairment by promoting ferroptosis in Alzheimer's
disease. Cell Death Differ. 28:1548–1562. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mahoney-Sánchez L, Bouchaoui H, Ayton S,
Devos D, Duce JA and Devedjian JC: Ferroptosis and its potential
role in the physiopathology of Parkinson's disease. Prog Neurobiol.
196:1018902021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Chen G and Shao W: Identification
of ferroptosis-related genes in Alzheimer's disease based on
bioinformatic analysis. Front Neurosci. 16:8237412022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang C, Chen S, Guo H, Jiang H, Liu H, Fu
H and Wang D: Forsythoside A mitigates Alzheimer's-like pathology
by inhibiting ferroptosis-mediated neuroinflammation via Nrf2/GPX4
axis activation. Int J Biol Sci. 18:2075–2090. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jakaria M, Belaidi AA, Bush AI and Ayton
S: Ferroptosis as a mechanism of neurodegeneration in Alzheimer's
disease. J Neurochem. 159:804–825. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defence is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alim I, Caulfield JT, Chen Y, Swarup V,
Geschwind DH, Ivanova E, Seravalli J, Ai Y, Sansing LH, Ste Marie
EJ, et al: Selenium drives a transcriptional adaptive program to
block ferroptosis and treat stroke. Cell. 177:1262–1279.e25. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ren JX, Li C, Yan XL, Qu Y, Yang Y and Guo
ZN: Crosstalk between oxidative stress and ferroptosis/oxytosis in
ischemic stroke: Possible targets and molecular mechanisms. Oxid
Med Cell Longev. 2021:66433822021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Si W, Sun B, Luo J, Li Z, Dou Y and Wang
Q: Snap25 attenuates neuronal injury via reducing ferroptosis in
acute ischemic stroke. Exp Neurol. 367:1144762023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kuriakose D and Xiao Z: Pathophysiology
and treatment of stroke: Present status and future perspectives.
Int J Mol Sci. 21:76092020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Y, Fang Y, Zhang Z, Luo Y, Zhang A,
Lenahan C and Chen S: Ferroptosis: An emerging therapeutic target
in stroke. J Neurochem. 160:64–73. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Prajapati M, Conboy HL, Hojyo S, Fukada T,
Budnik B and Bartnikas TB: Biliary excretion of excess iron in mice
requires hepatocyte iron import by Slc39a14. J Biol Chem.
297:1008352021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen Y, Fang ZM, Yi X, Wei X and Jiang DS:
The interaction between ferroptosis and inflammatory signaling
pathways. Cell Death Dis. 14:2052023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang W, Jing X, Du T, Ren J, Liu X, Chen
F, Shao Y, Sun S, Yang G and Cui X: Iron overload promotes
intervertebral disc degeneration via inducing oxidative stress and
ferroptosis in endplate chondrocytes. Free Radic Biol Med.
190:234–246. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shi F, Zhang Z, Cui H, Wang J, Wang Y,
Tang Y, Yang W, Zou P, Ling X, Han F, et al: Analysis by
transcriptomics and metabolomics for the proliferation inhibition
and dysfunction through redox imbalance-mediated DNA damage
response and ferroptosis in male reproduction of mice and TM4
Sertoli cells exposed to PM2.5. Ecotoxicol Environ Saf.
238:1135692022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin Q, Li S, Jin H, Cai H, Zhu X, Yang Y,
Wu J, Qi C, Shao X, Li J, et al: Mitophagy alleviates
cisplatin-induced renal tubular epithelial cell ferroptosis through
ROS/HO-1/GPX4 axis. Int J Biol Sci. 19:1192–1210. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Su LJ, Zhang JH, Gomez H, Murugan R, Hong
X, Xu D, Jiang F and Peng ZY: Reactive oxygen species-induced lipid
peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med
Cell Longev. 2019:50808432019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yuan Y, Zhai Y, Chen J, Xu X and Wang H:
Kaempferol ameliorates oxygen-glucose
deprivation/reoxygenation-induced neuronal ferroptosis by
activating Nrf2/SLC7A11/GPX4 axis. Biomolecules. 11:9232021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu H, Zhang T, Zhang WY, Huang SR, Hu Y
and Sun J: Rhein attenuates cerebral ischemia-reperfusion injury
via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
Exp Neurol. 369:1145412023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ralhan I, Chang J, Moulton MJ, Goodman LD,
Lee NYJ, Plummer G, Pasolli HA, Matthies D, Bellen HJ and Ioannou
MS: Autolysosomal exocytosis of lipids protect neurons from
ferroptosis. J Cell Biol. 222:e2022071302023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mamais A, Kluss JH, Bonet-Ponce L, Landeck
N, Langston RG, Smith N, Beilina A, Kaganovich A, Ghosh MC,
Pellegrini L, et al: Correction: Mutations in LRRK2 linked to
Parkinson disease sequester Rab8a to damaged lysosomes and regulate
transferrin-mediated iron uptake in microglia. PLoS Biol.
20:e30016212022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Reyhani A, McKenzie TG, Fu Q and Qiao GG:
Fenton-chemistry-mediated radical polymerization. Macromol Rapid
Commun. 40:19002202019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen Y, Yang Z, Wang S, Ma Q, Li L, Wu X,
Guo Q, Tao L and Shen X: Boosting ROS-mediated lysosomal membrane
permeabilization for cancer ferroptosis therapy. Adv Healthc Mater.
12:22021502023. View Article : Google Scholar
|
|
58
|
Von Krusenstiern AN, Robson RN, Qian N,
Qiu B, Hu F, Reznik E, Smith N, Zandkarimi F, Estes VM, Dupont M,
et al: Identification of essential sites of lipid peroxidation in
ferroptosis. Nat Chem Biol. 19:719–730. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ayala A, Muñoz MF and Argüelles S: Lipid
peroxidation: Production, metabolism, and signaling mechanisms of
malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev.
2014:3604382014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhu G, Chi H, Liu M, Yin Y, Diao H, Liu Z,
Guo Z, Xu W, Xu J, Cui C, et al: Multifunctional ‘ball-rod’ Janus
nanoparticles boosting Fenton reaction for ferroptosis therapy of
non-small cell lung cancer. J Colloid Interface Sci. 621:12–23.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kajarabille N and Latunde-Dada GO:
Programmed cell-death by ferroptosis: Antioxidants as mitigators.
Int J Mol Sci. 20:49682019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li J, Jia B, Cheng Y, Song Y, Li Q and Luo
C: Targeting Molecular mediators of ferroptosis and oxidative
stress for neurological disorders. Oxid Med Cell Longev.
2022:39990832022.PubMed/NCBI
|
|
63
|
Wan J, Ren H and Wang J: Iron toxicity,
lipid peroxidation and ferroptosis after intracerebral haemorrhage.
Stroke Vasc Neurol. 4:93–95. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Garton T, Keep RF, Hua Y and Xi G: CD163,
a hemoglobin/haptoglobin scavenger receptor, after intracerebral
hemorrhage: Functions in microglia/macrophages versus neurons.
Transl Stroke Res. 8:612–616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hare D, Ayton S, Bush A and Lei P: A
delicate balance: Iron metabolism and diseases of the brain. Front
Aging Neurosci. 5:342013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yang C, Hawkins KE, Doré S and
Candelario-Jalil E: Neuroinflammatory mechanisms of blood-brain
barrier damage in ischemic stroke. Am J Physiol Cell Physiol.
316:C135–C153. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bouchaoui H, Mahoney-Sanchez L, Garçon G,
Berdeaux O, Alleman LY, Devos D, Duce JA and Devedjian JC: ACSL4
and the lipoxygenases 15/15B are pivotal for ferroptosis induced by
iron and PUFA dyshomeostasis in dopaminergic neurons. Free Radic
Biol Med. 195:145–157. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rock C and Moos PJ: Selenoprotein P
protects cells from lipid hydroperoxides generated by 15-LOX-1.
Prostaglandins Leukot Essent Fatty Acids. 83:203–210. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Karuppagounder SS, Alim I, Khim SJ,
Bourassa MW, Sleiman SF, John R, Thinnes CC, Yeh TL, Demetriades M,
Neitemeier S, et al: Therapeutic targeting of oxygen-sensing prolyl
hydroxylases abrogates ATF4-dependent neuronal death and improves
outcomes after brain hemorrhage in several rodent models. Sci
Transl Med. 8:328ra292016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang H, Xu L, Tang X, Jiang Z and Feng X:
Lipid peroxidation-induced ferroptosis as a therapeutic target for
mitigating neuronal injury and inflammation in sepsis-associated
encephalopathy: Insights into the hippocampal PEBP-1/15-LOX/GPX4
pathway. Lipids Health Dis. 23:1282024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shah R, Shchepinov MS and Pratt DA:
Resolving the role of lipoxygenases in the initiation and execution
of ferroptosis. ACS Cent Sci. 4:387–396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Martami F and Holton KF: Targeting
glutamate neurotoxicity through dietary manipulation: Potential
treatment for migraine. Nutrients. 15:39522023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Saini KK, Chaturvedi P, Sinha A, Singh MP,
Khan MA, Verma A, Nengroo MA, Satrusal SR, Meena S, Singh A, et al:
Loss of PERK function promotes ferroptosis by downregulating
SLC7A11 (System Xc-) in colorectal cancer. Redox Biol.
65:1028332023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Dahlmanns M, Dahlmanns JK, Savaskan N,
Steiner HH and Yakubov E: Glial glutamate transporter-mediated
plasticity: System xc-/xCT/SLC7A11 and EAAT1/2 in brain
diseases. Front Biosci (Landmark Ed). 28:572023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Albrecht P, Lewerenz J, Dittmer S, Noack
R, Maher P and Methner A: Mechanisms of oxidative glutamate
toxicity: The glutamate/cystine antiporter system xc-as a
neuroprotective drug target. CNS Neurol Disord Drug Targets.
9:373–382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Puka-Sundvall M, Eriksson P, Nilsson M,
Sandberg M and Lehmann A: Neurotoxicity of cysteine: interaction
with glutamate. Brain Res. 705:65–70. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yuan Y, Yucai L, Lu L, Hui L, Yong P and
Haiyang Y: Acrylamide induces ferroptosis in HSC-T6 cells by
causing antioxidant imbalance of the XCT-GSH-GPX4 signaling and
mitochondrial dysfunction. Toxicol Lett. 368:24–32. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang W, Niu C, Liu Y and Chen B:
Glutathione redox balance in hibernating Chinese soft-shelled
turtle Pelodiscus sinensis hatchlings. Comp Biochem Physiol B
Biochem Mol Biol. 207:9–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Iskusnykh IY, Zakharova AA and Pathak D:
Glutathione in brain disorders and aging. Molecules. 27:3242022.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Miladinovic T and Singh G: Spinal
microglia contribute to cancer-induced pain through system
xC−-mediated glutamate release. Pain Rep.
4:e7382019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shen SY, Yu R, Li W, Liang LF, Han QQ,
Huang HJ, Li B, Xu SF, Wu GC, Zhang YQ and Yu J: The
neuroprotective effects of GPR55 against hippocampal
neuroinflammation and impaired adult neurogenesis in CSDS mice.
Neurobiol Dis. 169:1057432022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Chen Z and Trapp BD: Microglia and
neuroprotection. J Neurochem. 136 (Suppl 1):S10–S17. 2016.
View Article : Google Scholar
|
|
84
|
Frank D, Gruenbaum BF, Grinshpun J,
Melamed I, Severynovska O, Kuts R, Semyonov M, Brotfain E, Zlotnik
A and Boyko M: Measuring post-stroke cerebral edema, infarct zone
and blood-brain barrier breakdown in a single set of rodent brain
samples. J Vis Exp. 2020:e613092020.
|
|
85
|
Raper DMS and Abla AA: Commentary:
Encephalodu-roarteriosynangiosis averts stroke in atherosclerotic
patients with border-zone infarct: Post hoc analysis from a
performance criterion phase II trial. Neurosurgery. 88:E319–E320.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Fan G, Liu M, Liu J and Huang Y: The
initiator of neuroexcitotoxicity and ferroptosis in ischemic
stroke: Glutamate accumulation. Front Mol Neurosci. 16:11130812023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bridges R, Lutgen V, Lobner D and Baker
DA: Thinking outside the cleft to understand synaptic activity:
Contribution of the cystine-glutamate antiporter (System xc-) to
normal and pathological glutamatergic signaling. Pharmacol Rev.
64:780–802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Seibt TM, Proneth B and Conrad M: Role of
GPX4 in ferroptosis and its pharmacological implication. Free Radic
Biol Med. 133:144–152. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Liu J, Yang G and Zhang H:
Glyphosate-triggered hepatocyte ferroptosis via suppressing
Nrf2/GSH/GPX4 axis exacerbates hepatotoxicity. Sci Total Environ.
862:1608392023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Jin M, Shi C, Li T, Wu Y, Hu C and Huang
G: Solasonine promotes ferroptosis of hepatoma carcinoma cells via
glutathione peroxidase 4-induced destruction of the glutathione
redox system. Biomed Pharmacother. 129:1102822020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Delesderrier E, Monteiro JDC, Freitas S,
Pinheiro IC, Batista MS and Citelli M: Can iron and polyunsaturated
fatty acid supplementation induce ferroptosis? Cell Physiol
Biochem. 57:24–41. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Xie G, Liang Y, Gao W, Wu L, Zhang Y, Ye Z
and Qin C: Artesunate alleviates intracerebral haemorrhage
secondary injury by inducing ferroptosis in M1-polarized microglia
and suppressing inflammation through AMPK/mTORC1/GPX4 pathway.
Basic Clin Pharmacol Toxicol. 132:369–383. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Steinberg GR and Hardie DG: New insights
into activation and function of the AMPK. Nat Rev Mol Cell Biol.
24:255–272. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Muraleedharan R and Dasgupta B: AMPK in
the brain: Its roles in glucose and neural metabolism. FEBS J.
289:2247–2262. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Taghiyar S, Pourrajab F and Aarabi MH:
Astaxanthin improves fatty acid dysregulation in diabetes by
controlling the AMPK-SIRT1 pathway. EXCLI J. 22:502–515.
2023.PubMed/NCBI
|
|
96
|
Malik N, Ferreira BI, Hollstein PE, Curtis
SD, Trefts E, Weiser Novak S, Yu J, Gilson R, Hellberg K, Fang L,
et al: Induction of lysosomal and mitochondrial biogenesis by AMPK
phosphorylation of FNIP1. Science. 380:eabj55592023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Bae SJ, Bak SB and Kim YW: Coordination of
AMPK and YAP by Spatholobi caulis and procyanidin B2
provides antioxidant effects in vitro and in vivo. Int J Mol Sci.
23:137302022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lee H, Zandkarimi F, Zhang Y, Meena JK,
Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, et al:
Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat
Cell Biol. 22:225–234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Gao J, Li Y and Song R: SIRT2 inhibition
exacerbates p53-mediated ferroptosis in mice following experimental
traumatic brain injury. Neuroreport. 32:1001–1008. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lu W, Ji H and Wu D: SIRT2 plays complex
roles in neuroinflammation neuroimmunology-associated disorders.
Front Immunol. 14:11741802023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wu H, Liu Q, Shan X, Gao W and Chen Q: ATM
orchestrates ferritinophagy and ferroptosis by phosphorylating
NCOA4. Autophagy. 19:2062–2077. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Mi Y, Wei C, Sun L, Liu H, Zhang J, Luo J,
Yu X, He J, Ge H and Liu P: Melatonin inhibits ferroptosis and
delays age-related cataract by regulating SIRT6/p-Nrf2/GPX4 and
SIRT6/NCOA4/FTH1 pathways. Biomed Pharmacother. 157:1140482023.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Jin Y, Qiu J, Lu X and Li G: C-MYC
inhibited ferroptosis and promoted immune evasion in ovarian cancer
cells through NCOA4 mediated ferritin autophagy. Cells.
11:41272022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li C, Sun G, Chen B, Xu L, Ye Y, He J, Bao
Z, Zhao P, Miao Z, Zhao L, et al: Nuclear receptor coactivator
4-mediated ferritinophagy contributes to cerebral ischemia-induced
ferroptosis in ischemic stroke. Pharmacol Res. 174:1059332021.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Santana-Codina N, Gikandi A and Mancias
JD: The role of NCOA4-mediated ferritinophagy in ferroptosis.
Ferroptosis: Mechanism and Diseases. Vol. 1301. Florez AF and
Alborzinia H: Springer International Publishing; Cham: pp. 41–57.
2021, PubMed/NCBI
|
|
107
|
Fang Y, Chen X, Tan Q, Zhou H, Xu J and Gu
Q: Inhibiting ferroptosis through disrupting the NCOA4-FTH1
interaction: A new mechanism of action. ACS Cent Sci. 7:980–989.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Santana-Codina N, Gableske S, Quiles del
Rey M, Małachowska B, Jedrychowski MP, Biancur DE, Schmidt PJ,
Fleming MD, Fendler W, Harper JW, et al: NCOA4 maintains murine
erythropoiesis via cell autonomous and non-autonomous mechanisms.
Haematologica. 104:1342–1354. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Bellelli R, Federico G, Matte' A,
Colecchia D, Iolascon A, Chiariello M, Santoro M, De Franceschi L
and Carlomagno F: NCOA4 deficiency impairs systemic iron
homeostasis. Cell Rep. 14:411–421. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Nai A, Lidonnici MR, Federico G, Pettinato
M, Olivari V, Carrillo F, Geninatti Crich S, Ferrari G, Camaschella
C, Silvestri L and Carlomagno F: NCOA4-mediated ferritinophagy in
macrophages is crucial to sustain erythropoiesis in mice.
Haematologica. 106:795–805. 2021.PubMed/NCBI
|
|
111
|
Xu W, Guo ZN and Shao A: Editorial:
Ferroptosis in stroke, neurotrauma and neurodegeneration, volume
II. Front Cell Neurosci. 17:12384252023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Rochette L, Dogon G, Rigal E, Zeller M,
Cottin Y and Vergely C: Lipid peroxidation and iron metabolism: Two
corner stones in the homeostasis control of ferroptosis. Int J Mol
Sci. 24:4492022. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Wang L, Liu Y, Du T, Yang H, Lei L, Guo M,
Ding HF, Zhang J, Wang H, Chen X and Yan C: ATF3 promotes
erastin-induced ferroptosis by suppressing system Xc. Cell Death
Differ. 27:662–675. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Verbruggen L, Sprimont L, Bentea E,
Janssen P, Gharib A, Deneyer L, De Pauw L, Lara O, Sato H, Nicaise
C and Massie A: Chronic sulfasalazine treatment in mice induces
system xc−-independent adverse effects. Front Pharmacol.
12:6256992021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
de Baat A, Meier DT, Fontana A,
Böni-Schnetzler M and Donath MY: Cystine/Glutamate antiporter
system xc- deficiency impairs macrophage glutathione metabolism and
cytokine production. PLoS One. 18:e02919502023. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Sui X, Zhang R, Liu S, Duan T, Zhai L,
Zhang M, Han X, Xiang Y, Huang X, Lin H and Xie T: RSL3 drives
ferroptosis through GPX4 inactivation and ROS production in
colorectal cancer. Front Pharmacol. 9:13712018. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Cui C, Yang F and Li Q: Post-translational
modification of GPX4 is a promising target for treating
ferroptosis-related diseases. Front Mol Biosci. 9:9015652022.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Zhou J, Zhang L, Yan J, Hou A, Sui W and
Sun M: Curcumin induces ferroptosis in A549 CD133+ cells
through the GSH-GPX4 and FSP1-CoQ10-NAPH pathways. Discov Med.
35:251–263. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Almahi WA, Yu KN, Mohammed F, Kong P and
Han W: Hemin enhances radiosensitivity of lung cancer cells through
ferroptosis. Exp Cell Res. 410:1129462022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Ma S, Henson ES, Chen Y and Gibson SB:
Ferroptosis is induced following siramesine and lapatinib treatment
of breast cancer cells. Cell Death Dis. 7:e23072016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao
Y, Niu Y, Xu X, Guo S, Yang Y, et al: Endogenous glutamate
determines ferroptosis sensitivity via ADCY10-dependent YAP
suppression in lung adenocarcinoma. Theranostics. 11:5650–5674.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Sun S, Guo C, Gao T, Ma D, Su X, Pang Q
and Zhang R: Hypoxia enhances glioma resistance to
sulfasalazine-induced ferroptosis by upregulating SLC7A11 via
PI3K/AKT/HIF-1α axis. Oxid Med Cell Longev. 2022:78624302022.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhao Y, Li Y, Zhang R, Wang F, Wang T and
Jiao Y: The role of erastin in ferroptosis and its prospects in
cancer therapy. Onco Targets Ther. 13:5429–5441. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhang Y, Tan H, Daniels JD, Zandkarimi F,
Liu H, Brown LM, Uchida K, O'Connor OA and Stockwell BR: Imidazole
ketone erastin induces ferroptosis and slows tumor growth in a
mouse lymphoma model. Cell Chem Biol. 26:623–633.e9. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Duan L, Zhang Y, Yang Y, Su S, Zhou L, Lo
PC, Cai J, Qiao Y, Li M, Huang S, et al: Baicalin inhibits
ferroptosis in intracerebral hemorrhage. Front Pharmacol.
12:6293792021. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li J, Wei G, Song Z, Chen Z, Gu J, Zhang L
and Wang Z: SIRT5 regulates ferroptosis through the Nrf2/HO-1
signaling axis to participate in ischemia-reperfusion injury in
ischemic stroke. Neurochem Res. 49:998–1007. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Li Y, Bao Y, Li Y, Duan X, Dong S, Lin J,
Chang X, Tan Y, Zhang H and Shan H: RSL3 inhibits porcine epidemic
diarrhea virus replication by activating ferroptosis. Viruses.
15:20802023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Cheff DM, Huang C, Scholzen KC, Gencheva
R, Ronzetti MH, Cheng Q, Hall MD and Arnér ESJ: The ferroptosis
inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4
but of TXNRD1. Redox Biol. 62:1027032023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Hu J, Gu W, Ma N, Fan X and Ci X:
Leonurine alleviates ferroptosis in cisplatin-induced acute kidney
injury by activating the Nrf2 signalling pathway. Br J Pharmacol.
179:3991–4009. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X,
Jiang L and Ye L: Cetuximab promotes RSL3-induced ferroptosis by
suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant
colorectal cancer. Cell Death Dis. 12:10792021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Li S, He Y, Chen K, Sun J, Zhang L, He Y,
Yu H and Li Q: RSL3 drives ferroptosis through NF-κB pathway
activation and GPX4 depletion in glioblastoma. Oxid Med Cell
Longev. 2021:29150192021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Sun X, Huang N, Li P, Dong X, Yang J,
Zhang X, Zong WX, Gao S and Xin H: TRIM21 ubiquitylates GPX4 and
promotes ferroptosis to aggravate ischemia/reperfusion-induced
acute kidney injury. Life Sci. 321:1216082023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Li M, Meng Z, Yu S, Li J, Wang Y, Yang W
and Wu H: Baicalein ameliorates cerebral ischemia-reperfusion
injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3
axis. Chem Biol Interact. 366:1101372022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Nakamura T, Hipp C, Santos Dias Mourão A,
Borggräfe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E,
Lytton E, Emler D, et al: Phase separation of FSP1 promotes
ferroptosis. Nature. 619:371–377. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Yao X, Xie R, Cao Y, Tang J, Men Y, Peng H
and Yang W: Simvastatin induced ferroptosis for triple-negative
breast cancer therapy. J Nanobiotechnology. 19:3112021. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Shu X and Wu J, Zhang T, Ma X, Du Z, Xu J,
You J, Wang L, Chen N, Luo M and Wu J: Statin-induced
geranylgeranyl pyrophosphate depletion promotes ferroptosis-related
senescence in adipose tissue. Nutrients. 14:43652022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Miyamoto HD, Ikeda M, Ide T, Tadokoro T,
Furusawa S, Abe K, Ishimaru K, Enzan N, Sada M, Yamamoto T, et al:
Iron overload via heme degradation in the endoplasmic reticulum
triggers ferroptosis in myocardial ischemia-reperfusion injury.
JACC Basic Transl Sci. 7:800–819. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Chen GQ, Benthani FA, Wu J, Liang D, Bian
ZX and Jiang X: Artemisinin compounds sensitize cancer cells to
ferroptosis by regulating iron homeostasis. Cell Death Differ.
27:242–254. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Pei X, Tian M, Wang Y, Xin Y, Jiang J,
Wang Y and Gong Y: Advances in the knowledge on the role of
apoptosis repressor with caspase recruitment domain in hemorrhagic
stroke. J Intensive Med. 3:138–143. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Zille M, Karuppagounder SS, Chen Y, Gough
PJ, Bertin J, Finger J, Milner TA, Jonas EA and Ratan RR: Neuronal
death after hemorrhagic stroke in vitro and in vivo shares features
of ferroptosis and necroptosis. Stroke. 48:1033–1043. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Fu K, Xu W, Lenahan C, Mo Y, Wen J, Deng
T, Huang Q, Guo F, Mo L and Yan J: Autophagy regulates inflammation
in intracerebral hemorrhage: Enemy or friend? Front Cell Neurosci.
16:10363132023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Wang X, Mori T, Sumii T and Lo EH:
Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons:
Caspase activation and oxidative stress. Stroke. 33:1882–1888.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Xu Y, Liu Y, Li K, Yuan D, Yang S, Zhou L,
Zhao Y, Miao S, Lv C and Zhao J: COX-2/PGE2 pathway inhibits the
ferroptosis induced by cerebral ischemia reperfusion. Mol
Neurobiol. 59:1619–1631. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Dendorfer A, Heidbreder M, Hellwig-Bürgel
T, Jöhren O, Qadri F and Dominiak P: Deferoxamine induces prolonged
cardiac preconditioning via accumulation of oxygen radicals. Free
Radic Biol Med. 38:117–124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wang C, Xie L, Xing Y, Liu M, Yang J, Gao
N and Cai Y: Iron-overload-induced ferroptosis in mouse cerebral
toxoplasmosis promotes brain injury and could be inhibited by
Deferiprone. PLoS Negl Trop Dis. 17:e00116072023. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Miotto G, Rossetto M, Di Paolo ML, Orian
L, Venerando R, Roveri A, Vučković AM, Bosello Travain V, Zaccarin
M, Zennaro L, et al: Insight into the mechanism of ferroptosis
inhibition by ferrostatin-1. Redox Biol. 28:1013282020. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Gao Z, Zhang Z, Gu D, Li Y, Zhang K, Dong
X, Liu L, Zhang J, Chen J, Wu D and Zeng M: Hemin mitigates
contrast-induced nephropathy by inhibiting ferroptosis via
HO-1/Nrf2/GPX4 pathway. Clin Exp Pharma Physio. 49:858–870. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Mishima E, Ito J, Wu Z, Nakamura T, Wahida
A, Doll S, Tonnus W, Nepachalovich P, Eggenhofer E, Aldrovandi M,
et al: A non-canonical vitamin K cycle is a potent ferroptosis
suppressor. Nature. 608:778–783. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Sun W, Lv Z, Li W, Lu J, Xie Y, Wang P,
Jiang R, Dong J, Guo H, Liu Z, et al: XJB-5-131 protects
chondrocytes from ferroptosis to alleviate osteoarthritis
progression via restoring Pebp1 expression. J Orthop Translat.
44:114–124. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Liu Y, Wang W, Li Y, Xiao Y, Cheng J and
Jia J: The 5-lipoxygenase inhibitor zileuton confers
neuroprotection against glutamate oxidative damage by inhibiting
ferroptosis. Biol Pharm Bull. 38:1234–1239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Kosyakovsky J, Fine JM, Frey WH II and
Hanson LR: Mechanisms of intranasal deferoxamine in
neurodegenerative and neurovascular disease. Pharmaceuticals
(Basel). 14:952021. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Huang Z and Huang S: Reposition of the
fungicide ciclopirox for cancer treatment. Recent Pat Anticancer
Drug Discov. 16:122–135. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Averill-Bates DA: The antioxidant
glutathione. Vitam Horm. 121:109–141. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Chen J, Yang L, Geng L, He J, Chen L, Sun
Q, Zhao J and Wang X: Inhibition of Acyl-CoA synthetase long-chain
family member 4 facilitates neurological recovery after stroke by
regulation ferroptosis. Front Cell Neurosci. 15:6323542021.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Shen L, Lin D, Li X, Wu H, Lenahan C, Pan
Y, Xu W, Chen Y, Shao A and Zhang J: Ferroptosis in acute central
nervous system injuries: The future direction? Front Cell Dev Biol.
8:5942020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Guo Z, Lin J, Sun K, Guo J, Yao X, Wang G,
Hou L, Xu J, Guo J and Guo F: Deferoxamine alleviates
osteoarthritis by inhibiting chondrocyte ferroptosis and activating
the Nrf2 pathway. Front Pharmacol. 13:7913762022. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Xue Q, Yan D, Chen X, Li X, Kang R,
Klionsky DJ, Kroemer G, Chen X, Tang D and Liu J: Copper-dependent
autophagic degradation of GPX4 drives ferroptosis. Autophagy.
19:1982–1996. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang L, Zhang X, Xu M, Zheng G, Chen J, Li
S, Cui J and Zhang S: Implication of ferroptosis in hepatic
toxicity upon single or combined exposure to polystyrene
microplastics and cadmium. Environ Pollut. 334:1222502023.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Chen Y, He W, Wei H, Chang C, Yang L, Meng
J, Long T, Xu Q and Zhang C: Srs11-92, a ferrostatin-1 analog,
improves oxidative stress and neuroinflammation via Nrf2 signal
following cerebral ischemia/reperfusion injury. CNS Neurosci Ther.
29:1667–1677. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Holden P and Nair LS: Deferoxamine: An
angiogenic and antioxidant molecule for tissue regeneration. Tissue
Eng Part B Rev. 25:461–470. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Kim JL, Lee DH, Na YJ, Kim BR, Jeong YA,
Lee SI, Kang S, Joung SY, Lee SY, Oh SC and Min BW: Iron
chelator-induced apoptosis via the ER stress pathway in gastric
cancer cells. Tumor Biol. 37:9709–9719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Lin S, Gao W, Zhu C, Lou Q, Ye C, Ren Y,
Mehmood R, Huang B and Nan K: Efficiently suppress of ferroptosis
using deferoxamine nanoparticles as a new method for retinal
ganglion cell protection after traumatic optic neuropathy. Biomater
Adv. 138:2129362022. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
You H, Wang D, Wei L, Chen J, Li H and Liu
Y: Deferoxamine inhibits acute lymphoblastic leukemia progression
through repression of ROS/HIF-1α, Wnt/β-catenin, and p38MAPK/ERK
pathways. J Oncol. 2022:82812672022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Abdul Y, Li W, Ward R, Abdelsaid M, Hafez
S, Dong G, Jamil S, Wolf V, Johnson MH, Fagan SC and Ergul A:
Deferoxamine treatment prevents post-stroke vasoregression and
neurovascular unit remodeling leading to improved functional
outcomes in type 2 male diabetic rats: Role of endothelial
ferroptosis. Transl Stroke Res. 12:615–630. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Jones G, Zeng L and Kim J: Mechanism-based
pharmacokinetic modeling of absorption and disposition of a
deferoxamine-based nanochelator in rats. Mol Pharm. 20:481–490.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Chen X, Li D, Sun H, Wang W, Wu H and Kong
W and Kong W: Relieving ferroptosis may partially reverse
neurodegeneration of the auditory cortex. FEBS J. 287:4747–4766.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Tuo Q, Lei P, Jackman KA, Li XL, Xiong H,
Li XL, Liuyang ZY, Roisman L, Zhang ST, Ayton S, et al:
Tau-mediated iron export prevents ferroptotic damage after ischemic
stroke. Mol Psychiatry. 22:1520–1530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Kannan M, Sil S, Oladapo A, Thangaraj A,
Periyasamy P and Buch S: HIV-1 Tat-mediated microglial ferroptosis
involves the miR-204-ACSL4 signaling axis. Redox Biol.
62:1026892023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Li Y, Zeng X, Lu D, Yin M, Shan M and Gao
Y: Erastin induces ferroptosis via ferroportin-mediated iron
accumulation in endometriosis. Hum Reprod. 36:951–964. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Xie B, Wang Y, Lin Y, Mao Q, Feng J, Gao G
and Jiang J: Inhibition of ferroptosis attenuates tissue damage and
improves long-term outcomes after traumatic brain injury in mice.
CNS Neurosci Ther. 25:465–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Carbonell T and Rama R: Iron, oxidative
stress and early neurological deterioration in ischemic stroke.
Curr Med Chem. 14:857–874. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Silver MK, Lozoff B and Meeker JD: Blood
cadmium is elevated in iron deficient U.S. children: A
cross-sectional study. Environ Health. 12:1172013. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Zhang Q, Luo C, Li Z, Huang W, Zheng S,
Liu C, Shi X, Ma Y, Ni Q, Tan W, et al: Astaxanthin activates the
Nrf2/Keap1/HO-1 pathway to inhibit oxidative stress and
ferroptosis, reducing triphenyl phosphate (TPhP)-induced
neurodevelopmental toxicity. Ecotoxicol Environ Saf.
271:1159602024. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Liu X, Du Y, Liu J, Cheng L, He W and
Zhang W: Ferrostatin-1 alleviates cerebral ischemia/reperfusion
injury through activation of the AKT/GSK3β signaling pathway. Brain
Res Bull. 193:146–157. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Chen B and Jin W: A comprehensive review
of stroke-related signaling pathways and treatment in western
medicine and traditional Chinese medicine. Front Neurosci.
17:12000612023. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Lou Y, Ma M, Jiang Y, Xu H, Gao Z, Gao L
and Wang Y: Ferroptosis: A new strategy for traditional Chinese
medicine treatment of stroke. Biomed Pharmacother. 156:1138062022.
View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Li J, Zhao X, Zhang Y, Wan H, He Y, Li X,
Yu L and Jin W: Comparison of traditional Chinese medicine in the
long-term secondary prevention for patients with ischemic stroke: A
systematical analysis. Front Pharmacol. 12:7229752021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Zhu T, Wang L, Wang L and Wan Q:
Therapeutic targets of neuroprotection and neurorestoration in
ischemic stroke: Applications for natural compounds from medicinal
herbs. Biomed Pharmacother. 148:1127192022. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Wang J, Hu J, Chen X, Lei X, Feng H, Wan F
and Tan L: Traditional Chinese medicine monomers: Novel strategy
for endogenous neural stem cells activation after stroke. Front
Cell Neurosci. 15:6281152021. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Zhan S, Liang J, Lin H, Cai J, Yang X, Wu
H, Wei J, Wang S and Xian M: SATB1/SLC7A11/HO-1 axis ameliorates
ferroptosis in neuron cells after ischemic stroke by danhong
injection. Mol Neurobiol. 60:413–427. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Ko G, Kim J, Jeon YJ, Lee D, Baek HM and
Chang KA: Salvia miltiorrhiza alleviates memory deficit
induced by ischemic brain injury in a transient MCAO mouse model by
inhibiting ferroptosis. Antioxidants (Basel). 12:7852023.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Zhang J, Cai W, Wei X, Shi Y, Zhang K, Hu
C, Wan J, Luo K and Shen W: Moxibustion ameliorates cerebral
ischemia-reperfusion injury by regulating ferroptosis in rats. Clin
Exp Pharmacol Physiol. 50:779–788. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Liu J, Jiang G, He P, Du X, Hu Z and Li F:
Mechanism of ferroptosis in traditional chinese medicine for
clinical treatment: A review. Front Pharmacol. 13:11088362023.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Wang L, Liu C, Wang L and Tang B:
Astragaloside IV mitigates cerebral ischaemia-reperfusion injury
via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis. Eur
J Pharmacol. 944:1755162023. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Jiang Y, Zhao S, Zhou Y and Wei Z:
Research progress of traditional Chinese medicine in
ferroptosis-related diseases. Med Nov Technol Devices.
16:1001932022. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Yang K, Zeng L, Zeng J, Deng Y, Wang S, Xu
H, He Q, Yuan M, Luo Y, Ge A and Ge J: Research progress in the
molecular mechanism of ferroptosis in Parkinson's disease and
regulation by natural plant products. Ageing Res Rev.
91:1020632023. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Wu C, Duan F, Yang R, Dai Y, Chen X and Li
S: 15, 16-Dihydrotanshinone I protects against ischemic stroke by
inhibiting ferroptosis via the activation of nuclear factor
erythroid 2-related factor 2. Phytomedicine. 114:1547902023.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Bai X, Zheng E, Tong L, Liu Y, Li X and
Yang H, Jiang J, Chang Z and Yang H: Angong Niuhuang Wan inhibit
ferroptosis on ischemic and hemorrhagic stroke by activating
PPARγ/AKT/GPX4 pathway. J Ethnopharmacol. 321:1174382024.
View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Jin Z, Gao W, Guo F, Liao S, Hu M, Yu T,
Yu S and Shi Q: Astragaloside IV alleviates neuronal ferroptosis in
ischemic stroke by regulating fat mass and
obesity-associated-N6-methyladenosine-acyl-CoA synthetase
long-chain family member 4 axis. J Neurochem. 166:328–345. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Hirata Y, Cai R, Volchuk A, Steinberg BE,
Saito Y, Matsuzawa A, Grinstein S and Freeman SA: Lipid
peroxidation increases membrane tension, Piezo1 gating, and cation
permeability to execute ferroptosis. Curr Biol. 33:1282–1294.e5.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Gao W, Wang X, Zhou Y, Wang X and Yu Y:
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor
immunotherapy. Sig Transduct Target Ther. 7:1962022. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Zhou Y, Liao J, Mei Z, Liu X and Ge J:
Insight into crosstalk between ferroptosis and necroptosis: Novel
therapeutics in ischemic stroke. Oxid Med Cell Longev.
2021:99910012021. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G,
Liu Y, Zhao X, Qian L, Liu P and Xiong Y: Ferroptosis: A cell death
connecting oxidative stress, inflammation and cardiovascular
diseases. Cell Death Discov. 7:1932021. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Battaglia AM, Chirillo R, Aversa I, Sacco
A, Costanzo F and Biamonte F: Ferroptosis and cancer: Mitochondria
meet the ‘iron maiden’ cell death. Cells. 9:15052020. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Jeong SY and Seol DW: The role of
mitochondria in apoptosis. BMB Rep. 41:11–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun
C, Xu R and Zhang Z: ACSL4 exacerbates ischemic stroke by promoting
ferroptosis-induced brain injury and neuroinflammation. Brain Behav
Immun. 93:312–321. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Wang ZL, Yuan L, Li W and Li JY:
Ferroptosis in Parkinson's disease: Glia-neuron crosstalk. Trends
Mol Med. 28:258–269. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Ren JX, Sun X, Yan XL, Guo ZN and Yang Y:
Ferroptosis in neurological diseases. Front Cell Neurosci.
14:2182020. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Chen Y, Long T, Xu Q and Zhang C:
Bibliometric analysis of ferroptosis in stroke from 2013 to 2021.
Front Pharmacol. 12:8173642022. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Jin Y, Zhuang Y, Liu M, Che J and Dong X:
Inhibiting ferroptosis: A novel approach for stroke therapeutics.
Drug Discov Today. 26:916–930. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Yang K, Zeng L, Yuan X, Wang S, Ge A, Xu
H, Zeng J and Ge J: The mechanism of ferroptosis regulating
oxidative stress in ischemic stroke and the regulation mechanism of
natural pharmacological active components. Biomed Pharmacother.
154:1136112022. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Xing G, Meng L, Cao S, Liu S, Wu J, Li Q,
Huang W and Zhang L: PPARα alleviates iron overload-induced
ferroptosis in mouse liver. EMBO Rep. 23:e522802022. View Article : Google Scholar : PubMed/NCBI
|
